Sun, Dec 28, 2014, 11:19 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • tomyatahey tomyatahey Apr 3, 2014 8:42 AM Flag

    Drayton Wise as Senior Director of Commercial Operations

    Drayton Wise has joined as Senior Director of Commercial Operations reporting to Matthew Pauls, Chief Commercial Officer. He will focus on the design and build-out of key parts of the Company’s commercial infrastructure. Previously, Mr. Wise worked at Novartis, where he led the U.S. sales launch of the TOBI Podhaler, Novartis’ leading product for the treatment of CF.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • To be fair, the Novartis leadership won't be making much of an effort to retain any of the highly-paid personnel involved in Tobi commercialisation.

      You don't make it to the top of a company like Novartis without being able to see in advance the need to downsize an operation.

      • 1 Reply to fud.fighter2
      • Some background on Drayton Wise. Employed with Novartis since 1999. Must have great knowledge of product as well as clinics and doctors in the respiratory field. If approved, could ramp up sales pretty quick.

        Director, Cystic Fibrosis Sales & Account ManagementNovartis
        June 2012 – February 2014 (1 year 9 months)Cystic Fibrosis National Sales Director - Led national field force of Area Business Leaders, CF Account Managers, and Sales Specialists in highly successful new product launch.
        Director, Strategy & Commercial Operations - Respiratory Business UnitNovartis
        July 2011 – June 2012 (1 year)|East Hanover, NJ
        Head of Strategy & Commercial Operations group for $1 Billion multi-product (Allergic Asthma, CF, COPD, PAH) Specialty Business Unit. Served as key member of Executive Governance team with Joint Venture partner Genentech.

 
INSM
15.37+0.08(+0.52%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.